0
2019
U.s. Thrombectomy Devices Market

U.S. Thrombectomy Devices Market

by Technology (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, and Rheolytic Thrombectomy Devices), Type (Automated Thrombectomy Devices and Manual Thrombectomy Devices), Disease (Neurovascular Thrombectomy Devices, Peripheral Thrombectomy Devices, and Coronary Thrombectomy Devices), and Utility (Reusable Thrombectomy Devices and Disposable Thrombectomy Devices): Opportunity Analysis and Industry Forecast, 2018 - 2025

Report Code: A04832
Pages: 119
Tables: 34
Charts: 48
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

U.S. Thrombectomy Devices Market Outlook - 2025

The U.S. thrombectomy devices market was valued at $501.9 million in 2017, and is expected to reach $750.4 million by 2025. This market is anticipated to grow at a CAGR of 5.1% during the forecast period. Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. These devices are carefully designed to minimize damage to the vessel wall during the procedure, with minimum blood loss. They are available in different sizes and diameters, and depending on the affected area, the required catheter is chosen. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.

 

This is attributed by the increase in the incidence of chronic diseases due to the sedentary lifestyle and unhealthy living conditions and habits in the current generation. In addition, rise in geriatric population has led to increase in the incidence of cardiovascular diseases, which is expected to be one of the growth factors of the thrombectomy devices market. Furthermore, growth in demand for minimally invasive procedures and better healthcare infrastructure along with the increase in the competition has led to technological advancements and innovations. These factors are further anticipated to drive the thrombectomy devices market. However, lack of trained professionals and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by escaping the sedentary lifestyle and creating awareness among all age groups.

The report covers the U.S. thrombectomy devices market analysis based on five categories, which include technology, type, disease, and utility. Based on the technology used, the U.S. thrombectomy devices market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. Based on type, the market is divided into automated thrombectomy devices and manual thrombectomy devices. On the basis of utility of devices, the market is classified into reusable thrombectomy devices and disposable thrombectomy devices. Furthermore, the U.S. thrombectomy devices market is segmented into three types of diseases, namely, peripheral thrombectomy devices, coronary thrombectomy devices, and neurovascular thrombectomy devices.

 

The U.S. thrombectomy devices market size is analyzed by the technology vertical in the report. By technology, the mechanical U.S. thrombectomy devices market occupied the largest share in 2017, this trend is expected to continue throughout the forecast period as mechanical thrombectomy devices have replaced traditional manual aspiration thrombectomy devices due to better debulking of clot from large, proximal arteries. In addition, large vessel occlusions can be treated better by mechanical aspiration thrombectomy devices rather than chemical thrombolysis, which is usually futile.

 

The U.S. thrombectomy devices market share is also analyzed through type of devices. By type, manual thrombectomy devices occupied the largest share in 2017. Manual devices save electricity and reduce procedural cost in treating removal of thrombus. The trending manual devices include Export Aspiration Catheter by Medtronic plc, which is used to remove large venous clot without vessel occlusion. Other manual thrombectomy devices include the Pronto offered by Vascular Solutions, Solitaire FR Revascularization Device manufactured by Medtronic plc and others.

 

Furthermore, the U.S. thrombectomy devices market trends are also analyzed through diseases. By disease, the neurovascular thrombectomy devices are anticipated to occupy the largest share in 2025. Neurovascular thrombectomy devices are a widely preferred modality as they are more advantageous than intravenous (IV) recombinant tissue plasminogen activator in recanalization. Furthermore, they have high efficiency in treating large occlusions and they also decrease the risk of hemorrhage.
The growing competition and continuous technological advancements have led to acquisitions by major players in the U.S. thrombectomy devices market. For instance, in August 2017, Philips completed the acquisition of The Spectranetics Corporation, a U.S.-based global leader in vascular intervention and lead management solutions. Likewise, Penumbra Inc., executed the acquisition of a controlling interest in its joint venture, MVI Health Inc. After closing the transaction, Penumbra increased its ownership to 90% of the equity of MVI Health for $20 million in upfront cash consideration.

There have also been considerable product developments in the industry. For instance, U.S. FDA has cleared numerous thrombectomy devices recently. Penumbra Inc. received 510(k) clearance from the U.S. FDA to market its ACE64 aspiration thrombectomy system for the revascularization of large vessel occlusions in patients with acute ischemic stroke. Likewise, Medtronic plc's Neurovascular business unit received U.S. FDA clearance of the Riptide(TM) Aspiration System, this system is a part of the Acute Ischemic Stroke (AIS) product portfolio of the company. Furthermore, CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, received 510(k) clearance from the U.S. FDA for EMBOTRAP II Revascularization Device, a next generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.

The key players profiled in this report include Boston Scientific Corporation, Medtronic Plc., Teleflex Incorporated, Penumbra Inc., Koninklijke Philips N.V., AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Stryker Corporation, and Capture Vascular, Inc. The other players considered in the value chain analysis (but not in the report) include Argon Medical Devices, Inc., Inari Medical, Inc., and others.

Key Benefits for U.S. Thrombectomy Devices Market:

  • The report provides an extensive analysis of the current U.S. thrombectomy devices market trends and future estimations of the market.
  • The U.S. thrombectomy devices market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
  • The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 20182025.
  • Recent developments, key manufacturers, and market shares of U.S. thrombectomy devices market are listed in this report to analyze the competitive scenario of the market.

U.S. Thrombectomy Devices Market Report Highlights

Aspects Details
By Technology
  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic Thrombectomy Devices
By Type
  • Automated Thrombectomy Devices
  • Manual Thrombectomy Devices
By Disease
  • Neurovascular thrombectomy devices
  • Peripheral thrombectomy devices
  • Coronary thrombectomy devices
By Utility
  • Reusable Thrombectomy Devices
  • Disposable Thrombectomy Devices
Key Market Players Penumbra, Inc., Capture Vascular, Inc., Teleflex Incorporated, TERUMO MEDICAL CORPORATION, BOSTON SCIENTIFIC CORPORATION, Angiodynamics Inc., KONINKLIJKE PHILIPS N.V., Stryker Corporation, JOHNSON & JOHNSON, MEDTRONIC PLC
 

Loading Table Of Content...


 
 

The utilization of thrombectomy devices is expected to witness a significant rise with increase in application in treating neurovascular, peripheral, and coronary disorders. The thrombectomy devices market has piqued the interest of healthcare providers, as they can be used to treat clots efficiently. Devices such as mechanical, rheolytic, and aspiration thrombectomy products are used to treat peripheral, coronary, and neural clot-related diseases. Moreover, a remarkable increase in the usage of thrombectomy devices for the management of chronic disease patients has been observed since the past few years.

Some of the major factors that are expected to drive the market growth include rise in geriatric population, high demand for minimally invasive procedures & technological advancements, and innovations by key players. Furthermore, as per the CXOs, increase in incidence of cardiovascular diseases and need for better healthcare infrastructure fuel the growth of the market. However, lack of trained professionals, low awareness about thrombectomy devices, and complicated use of thrombectomy devices are the major factors that restrain the market growth.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample

Purchase Full Report of
U.s. Thrombectomy Devices Market

Start reading instantly.
This Report and over 71,231+ more Reports, Available with Avenue Library. T&C*.

  • Data Pack
  • $2,038
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2020 - Feb 2021)
  • Single User
  • $2,850
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2020 - Feb 2021)
  • Five Users
  • $3,423
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2020 - Feb 2021)
  • Enterprise
    License/PDF

  • $5,774
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2020 - Feb 2021)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers